Merck's Stock Faces Premarket Decline After Earnings Announcement
Market Chameleon (Tue, 4-Feb 8:42 AM)
Merck’s Mixed Earnings Call: Strong Growth Amid Challenges
at www.tipranks.com (Tue, 4-Feb 7:09 PM)
Merck projects $64.1B-$65.6B revenue in 2025 amid WINREVAIR growth and GARDASIL rebasing
at seekingalpha.com (Tue, 4-Feb 12:55 PM)
How this MRK Credit Put Spread Could Make 25% in 3 Days
Market Chameleon (Tue, 4-Feb 11:26 AM)
Biggest stock movers Tuesday: PLTR, PYPL, SPOT, and more
at seekingalpha.com (Tue, 4-Feb 9:54 AM)
MRK Earnings: Weak 2025 Guidance Mangles Merck Stock Today
at www.tipranks.com (Tue, 4-Feb 8:58 AM)
Merck's Gardasil Vaccine Slowdown In China Bites Again, Stock Falls On Weak 2025 Outlook
at www.benzinga.com (Tue, 4-Feb 8:34 AM)
Merck in Charts: KEYTRUDA continues growth trajectory with 18.6% rise in Q4
at seekingalpha.com (Tue, 4-Feb 7:29 AM)
Merck stock slides as 2025 earnings outlook misses estimates
at seekingalpha.com (Tue, 4-Feb 6:56 AM)
Earnings Snapshot: Merck FY25 sales outlook falls short of estimates even as Q4 beats
at seekingalpha.com (Tue, 4-Feb 6:51 AM)
Merck Non-GAAP EPS of $1.72 beats by $0.04, revenue of $15.62B beats by $110M
at seekingalpha.com (Tue, 4-Feb 6:32 AM)
Here's the major earnings before the open tomorrow
at seekingalpha.com (Mon, 3-Feb 6:00 PM)
Merck Q4 2024 Earnings Preview: Headwinds ahead, but familiar strengths to persist
at seekingalpha.com (Mon, 3-Feb 1:16 PM)
Sens. Wyden. Warren press RFK Jr. on conflicts of interest ahead of vote
at seekingalpha.com (Mon, 3-Feb 12:44 PM)